Trevi Therapeutics stock trades at USD 14.71 as biotech data matters

Published on 09/22/2026 at 09:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Trevi Therapeutics stock traded at USD 14.71 on September 21, 2026, down 1.61 percent. The shares remain above a USD 8.04 yearly low.

TRVI, US89357P1049, Illustration mit AI erstellt.

Trevi Therapeutics (ISIN US89357P1049) traded at USD 14.71 on Nasdaq on September 21, 2026, down 1.61 percent from the previous close. The stock's 52-week range was USD 8.04 to USD 20.22, placing the latest quote USD 5.51 below the yearly high and USD 6.67 above the yearly low.

Stock range remains wide

The intraday range recorded for September 21, 2026, was USD 14.70 to USD 15.11, while trading volume reached 337,494 shares. That volume was below the reported average of 1.70 million shares, a difference of 1.36 million shares, or about 80 percent.

The price profile matters because the distance between the 52-week low and high is USD 12.18. At USD 14.71, the stock stood USD 6.67, or 83.0 percent, above the low and USD 5.51, or 27.3 percent, below the high, based on the same September 21, 2026 market snapshot from MarketBeat.

Clinical progress drives valuation

Trevi Therapeutics is a clinical-stage biopharmaceutical company, so the share price is closely tied to development milestones, regulatory progress and the financing required to advance its pipeline. The available market data show a company whose valuation remains materially below its 52-week high despite the latest price being well above the yearly low.

For investors, the central comparison is therefore not only the daily decline of 1.61 percent, but also the broader USD 12.18 annual trading span. The 337,494-share session volume was approximately one-fifth of the stated 1.70 million-share average, which makes the September 21 move less informative than a move confirmed by substantially heavier turnover.

Trevi Therapeutics stock stays mid-range

Trevi Therapeutics stock closed at USD 14.71 on Nasdaq on September 21, 2026, after moving between USD 14.70 and USD 15.11 during the session. The quote remained 27.3 percent below the 52-week high of USD 20.22 and 83.0 percent above the 52-week low of USD 8.04.